Howard Berman - 22 Jan 2026 Form 4 Insider Report for Coya Therapeutics, Inc. (COYA)

Role: Executive Chairman, Director
Signature: /s/ David Snyder, Attorney-in-Fact
Issuer symbol: COYA
Transactions as of: 22 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 26 Jan 2026, 08:00:04 UTC
Previous filing: 24 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Berman Howard	Executive Chairman, Director	5850 SAN FELIPE ST., SUITE 500, HOUSTON	/s/ David Snyder, Attorney-in-Fact	26 Jan 2026	0001952986

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	COYA	Stock Option (right to buy)	Award	$0	+15,257		$0.000000	15,257	22 Jan 2026	Common Stock, par value $0.0001 per share	15,257	$4.73	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Subject to continuous service through each vesting date, the shares underlying the option will vest in monthly installments over the next 36 months. Upon a change in control of the Issuer, the shares underlying the option will vest and the option will become immediately exercisable pursuant to the Issuer's 2021 Equity Incentive Plan, as amended and restated effective November 17, 2022.